AVIR: Atea Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 311.41
Enterprise Value ($M) 167.59
Book Value ($M) 555.19
Book Value / Share 6.60
Price / Book 0.56
NCAV ($M) 550.68
NCAV / Share 6.54
Price / NCAV 0.57

Profitability (mra)
Return on Invested Capital (ROIC) -0.24
Return on Assets (ROA) -0.21
Return on Equity (ROE) -0.22

Liquidity (mrq)
Quick Ratio 18.24
Current Ratio 18.24

Balance Sheet (mrq) ($M)
Current Assets 590.46
Assets 594.97
Liabilities 39.78
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -164.16
Net Income -135.96

Cash Flow Statement (mra) ($M)
Cash From Operations -85.39
Cash from Investing 40.30
Cash from Financing 0.26

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A EcoR1 Capital, LLC 8.40 13.11
02-13 13G/A Sommadossi Jean-Pierre 9.60 9.20
02-13 13G/A Vanguard Group Inc 5.51 -24.47
02-09 13G/A Fmr Llc 6.41 -24.36
02-07 13G BML Investment Partners, L.P. 6.70 33.90
01-24 13G/A BlackRock Inc. 11.30 6.86
11-28 13D/A Tang Capital Partners Lp 4.80 33.27

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-25 18,308 111,157 16.47
2024-04-24 27,587 196,517 14.04
2024-04-23 15,275 73,781 20.70
2024-04-22 34,815 124,696 27.92

(click for more detail)

Similar Companies
ASMB – Assembly Biosciences, Inc. ATHA – Athira Pharma, Inc.
ATRA – Atara Biotherapeutics, Inc. AVRO – AVROBIO, Inc.
AVXL – Anavex Life Sciences Corp.


Financial data and stock pages provided by
Fintel.io


Finpedia: Aviragen Therapeutics